Incannex Healthcare (IXHL) Non Operating Income (2022 - 2026)
Incannex Healthcare's (IXHL) quarterly Non Operating Income came in at $165000.0 in Q1 2026, down 84.06% year-over-year from $1.0 million in Q1 2025, and down 65.19% quarter-over-quarter from $474000.0 in Q4 2025.
Analysis
Incannex Healthcare (IXHL) Non Operating Income (2022 - 2026) Analysis & Trends
Incannex Healthcare has disclosed Non Operating Income across 5 years of filings, most recently posting $165000.0 for Q1 2026.
- In Q1 2026, Non Operating Income fell 84.06% year-over-year to $165000.0; the TTM figure through Mar 2026 stood at -$23.0 million (down 637.02% YoY), while the FY2025 annual figure was -$23.1 million, down 298.9% from the prior year.
- Non Operating Income came in at $165000.0 for Q1 2026 at Incannex Healthcare, down from $474000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $4.2 million in Q3 2023 to a low of -$24.1 million in Q2 2025.
- Average Non Operating Income over 5 years is -$688857.1, with a median of $597500.0 recorded in 2022.
- Year-over-year, Non Operating Income soared 16465.0% in 2024 and sank 826.68% in 2025.
- Over 5 years, Non Operating Income stood at $721000.0 in 2022, then jumped by 280.31% to $2.7 million in 2023, then tumbled by 132.46% to -$890000.0 in 2024, then soared by 153.26% to $474000.0 in 2025, then tumbled by 65.19% to $165000.0 in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were $165000.0 in Q1 2026, $474000.0 in Q4 2025, and $387000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.50 Bn | 622.74 Bn | 17.26 Bn | - |
| 2 | AbbVie | 440.29 Bn | 433.72 Bn | 12.70 Bn | - |
| 3 | Merck | 364.93 Bn | 357.79 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.65 Bn | 258.96 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.92 Bn | 147.22 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - | -139.24 Mn |
| 8 | Incyte | 25.32 Bn | 20.78 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.42 Bn | 18.75 Bn | 683.80 Mn | 41.90 Mn |
| 10 | Incannex Healthcare | 41.43 Mn | 41.43 Mn | - | 165,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 165,000.00 |
| Dec 31, 2025 | 474,000.00 |
| Sep 30, 2025 | 387,000.00 |
| Jun 30, 2025 | -24.08 Mn |
| Mar 31, 2025 | 1.04 Mn |
| Dec 31, 2024 | -890,000.00 |
| Sep 30, 2024 | 834,000.00 |
| Jun 30, 2024 | 3.31 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Dec 31, 2023 | 2.74 Mn |
| Sep 30, 2023 | 4.17 Mn |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | 80,000.00 |
| Dec 31, 2022 | 721,000.00 |